Freenome is a blank check company seeking to combine with a healthcare, life sciences or medical technology business. It last closed at $9.82 on Nov 17, down 2.68% on the day. FRNM reports earnings on Wed, Dec 2, 2026. In the past 30 days there were 1 dark pool print totaling $1.5M, the largest $1.5M.
Only 1 firm rated FRNM in the past 90 days, not enough for a consensus
Average 12-month target
$21.00
▲ 113.8% upside
Based on 1 analyst who set a price target on FRNM in the past 90 days. The average target is $21.00, with a high of $21.00 and a low of $21.00, compared with the last close of $9.82.
Low $21.00Avg $21.00High $21.00
Blue marker: last close $9.82
Highest target$21.00
Average target$21.00
Lowest target$21.00
Latest rating changes
GuggenheimInitiated
Aug 20Buy$21
TD CowenInitiated
Aug 18Buy$17
JefferiesInitiated
Aug 17Buy$17
BTIGInitiated
Aug 17Buy$17
Leerink PartnersInitiated
Aug 14Buy$18
Date
Firm
Action
Rating
Price target
Aug 20
Guggenheim
Initiated
Buy
$21
Aug 18
TD Cowen
Initiated
Buy
$17
Aug 17
Jefferies
Initiated
Buy
$17
Aug 17
BTIG
Initiated
Buy
$17
Aug 14
Leerink Partners
Initiated
Buy
$18
Loading…
Technical Analysis
FRNM · as of the Nov 17 close · updated after every close
Falling, nearing oversold
The stock is 19% below its 20 day and 40% below its 50 day average. Momentum is weak (RSI 33), near oversold. The nearest support is the 52 week low at $9.71, and the nearest resistance the Pivot at $10.04.
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityHigh, 9.4%/day
Key levels
$17.5052 week high+78.2%
$13.7250 day average+39.7%
$13.05100 day average+32.9%
$11.6620 day average+18.7%
$11.40Swing high (Jun 25)+16.1%
$10.34Pivot R1+5.3%
$10.04Pivot+2.2%
$9.82Last close
$9.7152 week low−1.1%
$9.71Swing low (Nov 6)−1.1%
$9.52Pivot S1−3.1%
Indicators
RSI (14)
32.55
Weak, oversold below 30
Neutral
MACD
-1.00
Below its signal line
Bearish
Stochastic
9.9
Near the bottom of its range
Oversold
ADX (14)
30.6
Trending down
Williams %R
-97.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-100.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−14.4%
Change over 10 sessions
Bearish
ATR (14)
$0.93
Typical daily range, 9.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for FRNM
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how FRNM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Earnings in 14 daysSignals right before a report are less reliable. The report can override them.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Whale Options Flow
90D
No whale options trades in FRNM in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FRNM is in one of them and how their past FRNM trades turned out.
Freenome is a blank check company, a shell formed to acquire or combine with an operating business. It has no operating revenue yet and is focused on healthcare, especially life sciences and medical technology companies in North America or Europe. The company has entered into an agreement for a business combination with Freenome Holdings, Inc., which is subject to closing conditions. Freenome is based in Brisbane, California.